Teladoc Health Inc (TDOC) FinancialsTDOCTeladoc Health Inc

Teladoc Health Inc (TDOC) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Access Fees Revenue, accounting for 78.1% of total sales, equivalent to $474.21M. Another important revenue stream is Other. Understanding this composition is critical for investors evaluating how TDOC navigates market cycles within the Healthcare Facilities & Services industry.

Evaluating the bottom line, Teladoc Health Inc maintains a gross margin of 53.58%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -5.68%, while the net margin is -6.41%. These profitability ratios, combined with a Return on Equity (ROE) of -12.99%, provide a clear picture of how effectively TDOC converts its operational activities into shareholder value.

In the context of the broader market, TDOC competes directly with industry leaders such as USPH and GDRX. With a market capitalization of $1.24B, it holds a significant position in the sector. When comparing efficiency, TDOC's gross margin of 53.58% stands against USPH's 18.47% and GDRX's 78.41%. Such benchmarking helps identify whether Teladoc Health Inc is trading at a premium or discount relative to its financial performance.

Teladoc's latest quarterly revenue was $606.9 million, missing estimates by $9.43 million, and the company has lowered its full-year revenue guidance to between $2.36 billion and $2.45 billion, down from $2.48 billion to $2.58 billion.